<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37063839</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Association of atopic dermatitis with autoimmune diseases: A bidirectional and multivariable two-sample mendelian randomization study.</ArticleTitle><Pagination><StartPage>1132719</StartPage><MedlinePgn>1132719</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1132719</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1132719</ELocationID><Abstract><AbstractText Label="BACKGROUND">Observational studies have suggested the association between atopic dermatitis (AD) and the risks of autoimmune diseases. It is still unclear, however, whether or in which direction causal relationships exist, because these associations could be confounded.</AbstractText><AbstractText Label="OBJECTIVES">Our study seeks to assess the possibility of AD as a cause of autoimmune diseases, and to estimate the magnitude of the causal effect.</AbstractText><AbstractText Label="METHODS">Two-sample mendelian randomization (MR) analyses were performed using genome-wide association study (GWAS) summary-level statistics. Specifically, bidirectional MR analyses were conducted to examine the direction of association of AD with autoimmune diseases; multivariable MR analyses (MVMR1) were used to test the independence of causal association of AD with autoimmune diseases after controlling other atopic disorders (asthma and allergic rhinitis), while MVMR2 analyses were conducted to account for potential confounding factors such as smoking, drinking, and obesity. Genetic instruments for AD (Ncases=22 474) were from the latest GWAS meta-analysis. The GWAS summary data for asthma and allergic rhinitis were obtained from UK Biobank. The GWAS summary data for smoking, alcohol consumption, obesity and autoimmune diseases (alopecia areata, vitiligo, systemic lupus erythematosus, ankylosing spondylitis, rheumatoid arthritis, and type 1 diabetes) were selected from the largest GWASs available. Causal estimates were derived by the inverse-variance weighted method and verified through a series of sensitivity analyses.</AbstractText><AbstractText Label="RESULTS">Genetically predicted AD linked to higher risks of rheumatoid arthritis (OR, 1.28; P=0.0068) (OR<sub>MVMR1</sub>, 1.65; P=0.0020) (OR<sub>MVMR2</sub>, 1.36; P&lt;0.001), type 1 diabetes (OR, 1.37; P=0.0084) (OR<sub>MVMR1</sub>, 1.42; P=0.0155) (OR<sub>MVMR2</sub>, 1.45; P=0.002), and alopecia areata (OR, 1.98; P=0.0059) (OR<sub>MVMR1</sub>, 2.55; P&lt;0.001) (OR<sub>MVMR2</sub>, 1.99; P=0.003) in both univariable and multivariable MR. These causal relationships were supported by sensitivity analyses. No causal effect of AD was identified in relation to systemic lupus erythematosus, vitiligo, and ankylosing spondylitis. Concerning the reverse directions, no significant association was noted.</AbstractText><AbstractText Label="CONCLUSION">The results of this MR study provide evidence to support the idea that AD causes a greater risk of rheumatoid arthritis, type 1 diabetes and alopecia areata. Further replication in larger samples is needed to validate our findings, and experimental studies are needed to explore the underlying mechanisms of these causal effects.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Zhou, Cai, Li and Lin.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Weixin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zifan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Dermatology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C531609">Diffuse alopecia</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000506" MajorTopicYN="N">Alopecia Areata</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003876" MajorTopicYN="Y">Dermatitis, Atopic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="N">Mendelian Randomization Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065631" MajorTopicYN="N">Rhinitis, Allergic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013167" MajorTopicYN="N">Spondylitis, Ankylosing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014820" MajorTopicYN="N">Vitiligo</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">atopic dermatitis</Keyword><Keyword MajorTopicYN="N">autoimmune diseases</Keyword><Keyword MajorTopicYN="N">causality</Keyword><Keyword MajorTopicYN="N">mendelian randomization</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>3</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37063839</ArticleId><ArticleId IdType="pmc">PMC10098361</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1132719</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Laughter MR, Maymone M, Mashayekhi S, Arents B, Karimkhani C, Langan SM, et al. . The global burden of atopic dermatitis: lessons from the global burden of disease study 1990-2017. Br J Dermatol (2021) 184:304&#x2013;09. doi:&#xa0;10.1111/bjd.19580</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.19580</ArticleId><ArticleId IdType="pubmed">33006135</ArticleId></ArticleIdList></Reference><Reference><Citation>Paller A, Jaworski JC, Simpson EL, Boguniewicz M, Russell JJ, Block JK, et al. . Major comorbidities of atopic dermatitis: Beyond allergic disorders. Am J Clin Dermatol (2018) 19:821&#x2013;38. doi:&#xa0;10.1007/s40257-018-0383-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40257-018-0383-4</ArticleId><ArticleId IdType="pubmed">30168085</ArticleId></ArticleIdList></Reference><Reference><Citation>Slagor RM, N&#xf8;rreslet LB, Ebbeh&#xf8;j NE, Bonde JP, Thomsen SF, Agner T. Atopic dermatitis is associated with increased use of social benefits: a register-based cohort study. J Eur Acad Dermatol Venereol (2020) 34:549&#x2013;57. doi:&#xa0;10.1111/jdv.15902</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.15902</ArticleId><ArticleId IdType="pubmed">31442333</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe4;nder S. Atopic dermatitis. N Engl J Med (2021) 384:1136&#x2013;43. doi:&#xa0;10.1056/NEJMra2023911</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2023911</ArticleId><ArticleId IdType="pubmed">33761208</ArticleId></ArticleIdList></Reference><Reference><Citation>Bieber T. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat Rev Drug Discovery (2022) 21:21&#x2013;40. doi:&#xa0;10.1038/s41573-021-00266-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-021-00266-6</ArticleId><ArticleId IdType="pmc">PMC8377708</ArticleId><ArticleId IdType="pubmed">34417579</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuler CT, Billi AC, Maverakis E, Tsoi LC, Gudjonsson JE. Novel insights into atopic dermatitis. J Allergy Clin Immunol (2022). in press. doi:&#xa0;10.1016/j.jaci.2022.10.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2022.10.023</ArticleId><ArticleId IdType="pubmed">36428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivert LU, Wahlgren CF, Lindel&#xf6;f B, Dal H, Bradley M, Johansson EK. Association between atopic dermatitis and autoimmune diseases: a population-based case-control study. Br J Dermatol (2021) 185:335&#x2013;42. doi:&#xa0;10.1111/bjd.19624</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.19624</ArticleId><ArticleId IdType="pmc">PMC8451742</ArticleId><ArticleId IdType="pubmed">33091150</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipriani F, Marzatico A, Ricci G. Autoimmune diseases involving skin and intestinal mucosa are more frequent in adolescents and young adults suffering from atopic dermatitis. J Dermatol (2017) 44:1341&#x2013;48. doi:&#xa0;10.1111/1346-8138.14031</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1346-8138.14031</ArticleId><ArticleId IdType="pubmed">28925103</ArticleId></ArticleIdList></Reference><Reference><Citation>Narla S, Silverberg JI. Association between atopic dermatitis and autoimmune disorders in US adults and children: A cross-sectional study. J Am Acad Dermatol (2019) 80:382&#x2013;89. doi:&#xa0;10.1016/j.jaad.2018.09.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2018.09.025</ArticleId><ArticleId IdType="pubmed">30287311</ArticleId></ArticleIdList></Reference><Reference><Citation>Davey SG, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet (2014) 23:R89&#x2013;98. doi:&#xa0;10.1093/hmg/ddu328</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu328</ArticleId><ArticleId IdType="pmc">PMC4170722</ArticleId><ArticleId IdType="pubmed">25064373</ArticleId></ArticleIdList></Reference><Reference><Citation>Meisinger C, Freuer D. Causal association between atopic dermatitis and inflammatory bowel disease: A 2-sample bidirectional mendelian randomization study. Inflammation Bowel Dis (2022) 28:1543&#x2013;48. doi:&#xa0;10.1093/ibd/izab329</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izab329</ArticleId><ArticleId IdType="pubmed">34964870</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies NM, Holmes MV, Davey SG. Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians. Bmj (2018) 362:k601. doi:&#xa0;10.1136/bmj.k601</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k601</ArticleId><ArticleId IdType="pmc">PMC6041728</ArticleId><ArticleId IdType="pubmed">30002074</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munaf&#xf2; MR, et al. . Mendelian randomization. Nat Rev Methods Primers (2022) 2:6. doi:&#xa0;10.1038/s43586-021-00092-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43586-021-00092-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Thompson SG. Multivariable mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol (2015) 181:251&#x2013;60. doi:&#xa0;10.1093/aje/kwu283</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwu283</ArticleId><ArticleId IdType="pmc">PMC4325677</ArticleId><ArticleId IdType="pubmed">25632051</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliz E, Huilaja L, Pasanen A, Laisk T, Reimann E, M&#xe4;gi R, et al. . Uniting biobank resources reveals novel genetic pathways modulating susceptibility for atopic dermatitis. J Allergy Clin Immunol (2022) 149:1105&#x2013;12. doi:&#xa0;10.1016/j.jaci.2021.07.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2021.07.043</ArticleId><ArticleId IdType="pubmed">34454985</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Jia Q, Jahani PS, Hurrell BP, Pan C, Huang P, et al. . Genome-wide analysis highlights contribution of immune system pathways to the genetic architecture of asthma. Nat Commun (2020) 11:1776. doi:&#xa0;10.1038/s41467-020-15649-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15649-3</ArticleId><ArticleId IdType="pmc">PMC7160128</ArticleId><ArticleId IdType="pubmed">32296059</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, et al. . Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature (2014) 506:376&#x2013;81. doi:&#xa0;10.1038/nature12873</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12873</ArticleId><ArticleId IdType="pmc">PMC3944098</ArticleId><ArticleId IdType="pubmed">24390342</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentham J, Morris DL, Graham D, Pinder CL, Tombleson P, Behrens TW, et al. . Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet (2015) 47:1457&#x2013;64. doi:&#xa0;10.1038/ng.3434</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3434</ArticleId><ArticleId IdType="pmc">PMC4668589</ArticleId><ArticleId IdType="pubmed">26502338</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Andersen G, Yorgov D, Ferrara TM, Ben S, Brownson KM, et al. . Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nat Genet (2016) 48:1418&#x2013;24. doi:&#xa0;10.1038/ng.3680</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3680</ArticleId><ArticleId IdType="pmc">PMC5120758</ArticleId><ArticleId IdType="pubmed">27723757</ArticleId></ArticleIdList></Reference><Reference><Citation>Forgetta V, Manousaki D, Istomine R, Ross S, Tessier MC, Marchand L, et al. . Rare genetic variants of Large effect influence risk of type 1 diabetes. Diabetes (2020) 69:784&#x2013;95. doi:&#xa0;10.2337/db19-0831</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db19-0831</ArticleId><ArticleId IdType="pmc">PMC7085253</ArticleId><ArticleId IdType="pubmed">32005708</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Jiang Y, Wedow R, Li Y, Brazel DM, Chen F, et al. . Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet (2019) 51:237&#x2013;44. doi:&#xa0;10.1038/s41588-018-0307-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0307-5</ArticleId><ArticleId IdType="pmc">PMC6358542</ArticleId><ArticleId IdType="pubmed">30643251</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for mendelian randomization studies using multiple genetic variants. Int J Epidemiol (2011) 40:740&#x2013;52. doi:&#xa0;10.1093/ije/dyq151</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyq151</ArticleId><ArticleId IdType="pmc">PMC3147064</ArticleId><ArticleId IdType="pubmed">20813862</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce BL, Burgess S. Efficient design for mendelian randomization studies: Subsample and 2-sample instrumental variable estimators. Am J Epidemiol (2013) 178:1177&#x2013;84. doi:&#xa0;10.1093/aje/kwt084</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwt084</ArticleId><ArticleId IdType="pmc">PMC3783091</ArticleId><ArticleId IdType="pubmed">23863760</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Smith GD, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression. Int J Epidemiol (2015) 44:512&#x2013;25. doi:&#xa0;10.1093/ije/dyv080</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv080</ArticleId><ArticleId IdType="pmc">PMC4469799</ArticleId><ArticleId IdType="pubmed">26050253</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiology (2017) 28:30&#x2013;42. doi:&#xa0;10.1097/EDE.0000000000000559</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000000559</ArticleId><ArticleId IdType="pmc">PMC5133381</ArticleId><ArticleId IdType="pubmed">27749700</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Del Greco FM, Minelli C, Smith GD, Sheehan N, Thompson J. A framework for the investigation of pleiotropy in two-sample summary data mendelian randomization. Stat Med (2017) 36:1783&#x2013;802. doi:&#xa0;10.1002/sim.7221</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.7221</ArticleId><ArticleId IdType="pmc">PMC5434863</ArticleId><ArticleId IdType="pubmed">28114746</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck M, Chen C, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet (2018) 50:693. doi:&#xa0;10.1038/s41588-018-0099-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0099-7</ArticleId><ArticleId IdType="pmc">PMC6083837</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen TC, Lin CL, Wei CC, Chen CH, Tu CY, Hsia TC, et al. . The risk of asthma in patients with ankylosing spondylitis: a population-based cohort study. PloS One (2015) 10:e116608. doi:&#xa0;10.1371/journal.pone.0116608</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0116608</ArticleId><ArticleId IdType="pmc">PMC4320111</ArticleId><ArticleId IdType="pubmed">25658339</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoenngam N, Ponvilawan B, Rittiphairoj T, Tornsatitkul S, Wattanachayakul P, Rujirachun P, et al. . Patients with asthma have a higher risk of rheumatoid arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum (2020) 50:968&#x2013;76. doi:&#xa0;10.1016/j.semarthrit.2020.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2020.07.015</ArticleId><ArticleId IdType="pubmed">32906033</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi BY, Han M, Kwak JW, Kim TH. Genetics and epigenetics in allergic rhinitis. Genes (Basel) (2021) 12:2004. doi:&#xa0;10.3390/genes12122004</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes12122004</ArticleId><ArticleId IdType="pmc">PMC8700872</ArticleId><ArticleId IdType="pubmed">34946955</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoenngam N, Ponvilawan B, Wongtrakul W, Ungprasert P. Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis. Clin Rheumatol (2021) 40:529&#x2013;36. doi:&#xa0;10.1007/s10067-020-05279-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05279-x</ArticleId><ArticleId IdType="pubmed">32638252</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn K, Penn RB, Rattan S, Panettieri RJ, Voight BF, An SS. Mendelian randomization analysis reveals a complex genetic interplay among atopic dermatitis, asthma, and gastroesophageal reflux disease. Am J Respir Crit Care Med (2023) 207:130&#x2013;37. doi:&#xa0;10.1164/rccm.202205-0951oc</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202205-0951oc</ArticleId><ArticleId IdType="pmc">PMC9893317</ArticleId><ArticleId IdType="pubmed">36214830</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Chen G, Liang T, Li A, Liu W, Wang Y, et al. . Childhood asthma and type 1 diabetes mellitus: A meta-analysis and bidirectional mendelian randomization study. Pediatr Allergy Immunol (2022) 33:e13858. doi:&#xa0;10.1111/pai.13858</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.13858</ArticleId><ArticleId IdType="pubmed">36156818</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai YX, Yeh FY, Shen YJ, Tai YH, Chou YJ, Chang YT, et al. . Cigarette smoking, alcohol consumption, and risk of alopecia areata: a population-based cohort study in Taiwan. Am J Clin Dermatol (2020) 21:901&#x2013;11. doi:&#xa0;10.1007/s40257-020-00547-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40257-020-00547-7</ArticleId><ArticleId IdType="pubmed">32761499</ArticleId></ArticleIdList></Reference><Reference><Citation>Molla GJ, Ismail-Beigi F, Larijani B, Khaloo P, Moosaie F, Alemi H, et al. . Smoking and diabetes control in adults with type 1 and type 2 diabetes: A nationwide study from the 2018 National Program for Prevention and Control of Diabetes of Iran. Can J Diabetes (2020) 44:246&#x2013;52. doi:&#xa0;10.1016/j.jcjd.2019.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjd.2019.07.002</ArticleId><ArticleId IdType="pubmed">31494031</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianfrancesco MA, Crowson CS. Where There's Smoke, There's a Joint: Passive Smoking and Rheumatoid Arthritis. Arthritis Rheumatol (2021) 73:2161&#x2013;62. doi:&#xa0;10.1002/art.41940</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41940</ArticleId><ArticleId IdType="pmc">PMC8671157</ArticleId><ArticleId IdType="pubmed">34347946</ArticleId></ArticleIdList></Reference><Reference><Citation>VanEvery H, Yang W, Olsen N, Bao L, Lu B, Wu S, et al. . Alcohol Consumption and Risk of Rheumatoid Arthritis among Chinese Adults: A Prospective Study. Nutrients (2021) 13:2231. doi:&#xa0;10.3390/nu13072231</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13072231</ArticleId><ArticleId IdType="pmc">PMC8308382</ArticleId><ArticleId IdType="pubmed">34209676</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang B, Shi H, Alfredsson L, Klareskog L, Padyukov L, Jiang X. Obesity-related traits and the development of rheumatoid arthritis: Evidence from genetic data. Arthritis Rheumatol (2021) 73:203&#x2013;11. doi:&#xa0;10.1002/art.41517</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41517</ArticleId><ArticleId IdType="pmc">PMC7898325</ArticleId><ArticleId IdType="pubmed">32964675</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucker I, Zloof Y, Bardugo A, Tsur AM, Lutski M, Cohen Y, et al. . Obesity in late adolescence and incident type 1 diabetes in young adulthood. Diabetologia (2022) 65:1473&#x2013;82. doi:&#xa0;10.1007/s00125-022-05722-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-022-05722-5</ArticleId><ArticleId IdType="pubmed">35665825</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lusignan S, Alexander H, Broderick C, Dennis J, McGovern A, Feeney C, et al. . Atopic dermatitis and risk of autoimmune conditions: Population-based cohort study. J Allergy Clin Immunol (2022) 150:709&#x2013;13. doi:&#xa0;10.1016/j.jaci.2022.03.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2022.03.030</ArticleId><ArticleId IdType="pubmed">35469843</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen YM, Egeberg A, Gislason GH, Skov L, Thyssen JP. Autoimmune diseases in adults with atopic dermatitis. J Am Acad Dermatol (2017) 76:274&#x2013;80. doi:&#xa0;10.1016/j.jaad.2016.08.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2016.08.047</ArticleId><ArticleId IdType="pubmed">27742171</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Z, Zeng N, Cheng Y, Chen Y, Li Y, Lu Q, et al. . Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis. Allergy Asthma Clin Immunol (2021) 17:96. doi:&#xa0;10.1186/s13223-021-00597-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13223-021-00597-4</ArticleId><ArticleId IdType="pmc">PMC8467008</ArticleId><ArticleId IdType="pubmed">34563251</ArticleId></ArticleIdList></Reference><Reference><Citation>Rittiphairoj T, Charoenngam N, Ponvilawan B, Tornsatitkul S, Wattanachayakul P, Rujirachun P, et al. . Atopic dermatitis is a risk factor for rheumatoid arthritis: A systematic review and meta-analysis. Dermatitis (2021) 32:S15&#x2013;23. doi:&#xa0;10.1097/DER.0000000000000781</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DER.0000000000000781</ArticleId><ArticleId IdType="pubmed">34405833</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan GC, Silverberg JI. Association of vitiligo and alopecia areata with atopic dermatitis: A systematic review and meta-analysis. JAMA Dermatol (2015) 151:522&#x2013;28. doi:&#xa0;10.1001/jamadermatol.2014.3324</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamadermatol.2014.3324</ArticleId><ArticleId IdType="pubmed">25471826</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer HU, H&#xe4;upl T, Burmester GR. The etiology of rheumatoid arthritis. J Autoimmun (2020) 110:102400. doi:&#xa0;10.1016/j.jaut.2019.102400</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102400</ArticleId><ArticleId IdType="pubmed">31980337</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Gao J, Kang J, Wang X, Niu Q, Liu J, et al. . B cells in rheumatoid Arthritis: Pathogenic mechanisms and treatment prospects. Front Immunol (2021) 12:750753. doi:&#xa0;10.3389/fimmu.2021.750753</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.750753</ArticleId><ArticleId IdType="pmc">PMC8505880</ArticleId><ArticleId IdType="pubmed">34650569</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu N, Win S, Yan M, Huynh NC, Sawa S, Tsukasaki M, et al. . Plasma cells promote osteoclastogenesis and periarticular bone loss in autoimmune arthritis. J Clin Invest (2021) 131:e143060. doi:&#xa0;10.1172/JCI143060</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI143060</ArticleId><ArticleId IdType="pmc">PMC7954598</ArticleId><ArticleId IdType="pubmed">33720039</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugaya M. The role of Th17-related cytokines in atopic dermatitis. Int J Mol Sci (2020) 21:1314. doi:&#xa0;10.3390/ijms21041314</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21041314</ArticleId><ArticleId IdType="pmc">PMC7072946</ArticleId><ArticleId IdType="pubmed">32075269</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P, Qian FY, Zhang MF, Xu AL, Wang X, Jiang BP, et al. . Th17 cell pathogenicity and plasticity in rheumatoid arthritis. J Leukoc Biol (2019) 106:1233&#x2013;40. doi:&#xa0;10.1002/JLB.4RU0619-197R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.4RU0619-197R</ArticleId><ArticleId IdType="pubmed">31497905</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C, Perdriger A, Am&#xe9; P. Definition of b cell helper T cells in rheumatoid arthritis and their behavior during treatment. Semin Arthritis Rheum (2020) 50:867&#x2013;72. doi:&#xa0;10.1016/j.semarthrit.2020.06.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2020.06.021</ArticleId><ArticleId IdType="pubmed">32896702</ArticleId></ArticleIdList></Reference><Reference><Citation>DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet (2018) 391:2449&#x2013;62. doi:&#xa0;10.1016/S0140-6736(18)31320-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)31320-5</ArticleId><ArticleId IdType="pmc">PMC6661119</ArticleId><ArticleId IdType="pubmed">29916386</ArticleId></ArticleIdList></Reference><Reference><Citation>Syed FZ. Type 1 diabetes mellitus. Ann Intern Med (2022) 175:C33&#x2013;48. doi:&#xa0;10.7326/AITC202203150</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/AITC202203150</ArticleId><ArticleId IdType="pubmed">35254878</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe1;sp&#xe1;r K, Bar&#xe1;th S, Nagy G, M&#xf3;csai G, Gyimesi E, Szodoray P, et al. . Regulatory T-cell subsets with acquired functional impairment: important indicators of disease severity in atopic dermatitis. Acta Derm Venereol (2015) 95:151&#x2013;55. doi:&#xa0;10.2340/00015555-1882</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/00015555-1882</ArticleId><ArticleId IdType="pubmed">24890798</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll KR, Katz JD. Restoring tolerance to &#x3b2;-cells in type 1 diabetes: Current and emerging strategies. Cell Immunol (2022) 380:104593. doi:&#xa0;10.1016/j.cellimm.2022.104593</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2022.104593</ArticleId><ArticleId IdType="pubmed">36081179</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Skowronek I, Sieniawska J, Pach E, Wrobel W, Skowronek A, Tomczyk Z, et al. . Potential therapeutic application of regulatory T cells in diabetes mellitus type 1. Int J Mol Sci (2021) 23:390. doi:&#xa0;10.3390/ijms23010390</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23010390</ArticleId><ArticleId IdType="pmc">PMC8745590</ArticleId><ArticleId IdType="pubmed">35008819</ArticleId></ArticleIdList></Reference><Reference><Citation>Solt LA, Burris TP. Th17 cells in type 1 diabetes: a future perspective. Diabetes Manage (London England) (2015) 5:247&#x2013;50. doi: 10.2217/DMT.15.19</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/DMT.15.19</ArticleId><ArticleId IdType="pmc">PMC5046833</ArticleId><ArticleId IdType="pubmed">27708719</ArticleId></ArticleIdList></Reference><Reference><Citation>Roeleveld DM, Koenders MI. The role of the Th17 cytokines IL-17 and IL-22 in rheumatoid arthritis pathogenesis and developments in cytokine immunotherapy. Cytokine (2015) 74:101&#x2013;07. doi:&#xa0;10.1016/j.cyto.2014.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2014.10.006</ArticleId><ArticleId IdType="pubmed">25466295</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Li X, Wang C, Zhang J. Alopecia areata: an update on etiopathogenesis, diagnosis, and management. Clin Rev Allergy Immunol (2021) 61:403&#x2013;23. doi:&#xa0;10.1007/s12016-021-08883-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08883-0</ArticleId><ArticleId IdType="pubmed">34403083</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng J, Li Y, Fischer M, Steinhoff M, Chen W, Wang J. Th2 modulation of transient receptor potential channels: An unmet therapeutic intervention for atopic dermatitis. Front Immunol (2021) 12:696784. doi:&#xa0;10.3389/fimmu.2021.696784</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.696784</ArticleId><ArticleId IdType="pmc">PMC8278285</ArticleId><ArticleId IdType="pubmed">34276687</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito T, Kageyama R, Nakazawa S, Honda T. Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata. Exp Dermatol (2020) 29:726&#x2013;32. doi:&#xa0;10.1111/exd.14129</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/exd.14129</ArticleId><ArticleId IdType="pubmed">32533873</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Kim BE, Leung D. Pathophysiology of atopic dermatitis: Clinical implications. Allergy Asthma Proc (2019) 40:84&#x2013;92. doi:&#xa0;10.2500/aap.2019.40.4202</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/aap.2019.40.4202</ArticleId><ArticleId IdType="pmc">PMC6399565</ArticleId><ArticleId IdType="pubmed">30819278</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanemura A, Oiso N, Nakano M, Itoi S, Kawada A, Katayama I. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles. Dermatology (2013) 226:333&#x2013;36. doi:&#xa0;10.1159/000350933</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000350933</ArticleId><ArticleId IdType="pubmed">23838575</ArticleId></ArticleIdList></Reference><Reference><Citation>Paternoster L, Standl M, Waage J, Baurecht H, Hotze M, Strachan DP, et al. . Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat Genet (2015) 47:1449&#x2013;56. doi:&#xa0;10.1038/ng.3424</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3424</ArticleId><ArticleId IdType="pmc">PMC4753676</ArticleId><ArticleId IdType="pubmed">26482879</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagielska D, Redler S, Brockschmidt FF, Herold C, Pasternack SM, Garcia BN, et al. . Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance. J Invest Dermatol (2012) 132:2192&#x2013;97. doi:&#xa0;10.1038/jid.2012.129</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2012.129</ArticleId><ArticleId IdType="pubmed">22534877</ArticleId></ArticleIdList></Reference><Reference><Citation>Betz RC, Pforr J, Flaquer A, Redler S, Hanneken S, Eigelshoven S, et al. . Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. J Invest Dermatol (2007) 127:2539&#x2013;43. doi:&#xa0;10.1038/sj.jid.5700915</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.jid.5700915</ArticleId><ArticleId IdType="pubmed">17581619</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada K, Irisawa R, Ito T, Uchiyama M, Tsuboi R. The effectiveness of dupilumab in patients with alopecia areata who have atopic dermatitis: a case series of seven patients. Br J Dermatol (2020) 183:396&#x2013;97. doi:&#xa0;10.1111/bjd.18976</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.18976</ArticleId><ArticleId IdType="pubmed">32118289</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan D, Fan H, Chen M, Xia L, Wang S, Dong W, et al. . The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies. Front Pharmacol (2022) 13:950450. doi:&#xa0;10.3389/fphar.2022.950450</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.950450</ArticleId><ArticleId IdType="pmc">PMC9449963</ArticleId><ArticleId IdType="pubmed">36091777</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttman-Yassky E, Renert-Yuval Y, Bares J, Chima M, Hawkes JE, Gilleaudeau P, et al. . Phase 2a randomized clinical trial of dupilumab (anti-IL-4R&#x3b1;) for alopecia areata patients. Allergy (2022) 77:897&#x2013;906. doi:&#xa0;10.1111/all.15071</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15071</ArticleId><ArticleId IdType="pmc">PMC9997752</ArticleId><ArticleId IdType="pubmed">34460948</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>